跳至主要内容
临床试验/NCT01443273
NCT01443273Unknown不适用

Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
The frequency of thrombophilic risk factors in preterms and infants

研究概览

简要总结

There are several factor that can be related to Neonatal Thrombotic events. Among them hypercoagulability can be the cause of those events. Factor V Leiden (FVL) and Prothrombin mutation are the most common causes of hereditary thrombophilia. The incidence of in the arab population is known to be higher than the incidence in another western populations. The purpose of this study is to review retrospectively the thrombophilic risk factors that were found in a cohort of premature babies and term newborns treated and investigated at the Neonatal Intensive Care Unit and at the Pediatric Hematology Unit.

详细描述

All the demographic and clinical data will be summarized. Factors non related to the coagulation system like catheters, severe infections or congenital heart defects will be recorded. Also a full workup of prothrombotic risk factors are routinely performed in those infants. The study included basic coagulation analysis, Protein C, S and Antithrombin III activity, Activated Protein C Resistance, serum homocystein, lipoprotein (a) and Lupus Anticoagulant.

Also the three common genetic factors are analysed including Factor F Leiden (G1691A), Prothrombin Mutation (G20210A) and MTHFR polymorphism (C677T).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 1 Year(Child)
性别
All
接受健康志愿者

入选标准

  • All newborns (Term and Premature) diagnosed with Neonatal Thrombotic events between year 1990 to 2010.

排除标准

  • 未提供

结局指标

主要结局

The frequency of thrombophilic risk factors in preterms and infants

时间窗: One year

Recruitment of all premature and term infants born at Emek Medical Center and suffer from thrombotic events.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Koren Ariel

Head of Pediatric Dpt B and Pediatric Hematology Unit and

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验